Letter from S L Holst, Hyland Therapeutics Division, Travenol Laboratories Inc, to Customers, regarding its announcement of the discontinuation and market withdrawal of non-treated anti-haemophilic Factor (Human), HEMOFIL, and Factor IX Complex, PROPLEX SX, due to the risk of AIDS transmission through untreated product